{"id":"W2979480540","doi":"10.1016/j.clinthera.2019.09.008","title":"Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China","year":2019,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"China Medical Board","keywords":"Medicine; Osimertinib; Docetaxel; T790M; Oncology; Pemetrexed; Lung cancer; Internal medicine; Epidermal growth factor receptor; Cost effectiveness; Gemcitabine; Cancer; Chemotherapy; Erlotinib; Gefitinib; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001978964,0.0002240977,0.0006839286,0.00009494471,0.00001682162,0.000005572321,0.00007246608,0.000132069,0.0001804853],"category_scores_gemma":[0.00001248301,0.0001529944,0.0001092835,0.0003023183,0.00005912951,0.00005327816,0.0000178282,0.0002121259,0.00001037442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004093103,"about_ca_system_score_gemma":0.0004509883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002254668,"about_ca_topic_score_gemma":0.0002294155,"domain_scores_codex":[0.9984812,0.0001500394,0.0005826839,0.0003725748,0.0001512049,0.000262309],"domain_scores_gemma":[0.9988884,0.0003677649,0.0002032072,0.0003252676,0.0001179937,0.00009738986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004437836,0.003611624,0.9649978,0.0001813204,0.0003983216,0.00001204716,0.0005806823,0.001224215,0.0003698169,0.000005430781,8.42132e-7,0.02418004],"study_design_scores_gemma":[0.03767772,0.005082293,0.9510404,0.0005489073,0.0004197402,5.130535e-7,0.00006871814,0.001109198,0.003549708,0.00002177825,0.0003182277,0.0001627661],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944274,0.0004589654,0.00003313366,0.00007925722,0.0002138824,0.003763388,0.00006414419,0.00001688627,0.0009428902],"genre_scores_gemma":[0.9982715,0.0002671941,0.0002185348,0.0002681043,0.00002040209,0.0002735304,0.00009725339,0.00003973383,0.0005437533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03323988,"threshold_uncertainty_score":0.623893,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03739784824940182,"score_gpt":0.4140337343373992,"score_spread":0.3766358860879974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}